TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked May 15, 1981
TCL Archive FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test March 28, 2014
TCL Archive “The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts” October 28, 1994
